HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anesthetic management of a patient with congenital plasminogen activator inhibitor-1 deficiency].

Abstract
Congenital plasminogen activator inhibitor-1 (PAI-1) deficiency is an extremely rare disorder characterized by a bleeding diathesis due to hyperfibrinolysis as a result of decreased PAI-1 activity. A 21-year-old male with congenital PAI-1 deficiency underwent wisdom teeth extraction of the mandible under general anesthesia using propofol, nitrous oxide, sevoflurane, fentanyl, and vecuronium. No complications including prolonged bleeding and rebleeding after the operation were observed because hemostatic management was successful by using intravenous tranexamic acid.
AuthorsAtsuhisa Kajihara, Hiroyoshi Kurehara, Katsuyasu Kitaguchi, Hitoshi Furuya, Yoshinari Morimoto, Tadaaki Kirita, Kazuyoshi Fukuda, Yukihiro Takahashi
JournalMasui. The Japanese journal of anesthesiology (Masui) Vol. 52 Issue 1 Pg. 73-5 (Jan 2003) ISSN: 0021-4892 [Print] Japan
PMID12632627 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antifibrinolytic Agents
  • Plasminogen Activator Inhibitor 1
  • Tranexamic Acid
Topics
  • Adult
  • Anesthesia, General
  • Antifibrinolytic Agents (administration & dosage)
  • Blood Loss, Surgical (prevention & control)
  • Humans
  • Male
  • Molar, Third (surgery)
  • Perioperative Care
  • Plasminogen Activator Inhibitor 1 (deficiency)
  • Tooth Extraction
  • Tranexamic Acid (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: